32
Participants
Start Date
January 1, 2025
Primary Completion Date
July 1, 2025
Study Completion Date
September 1, 2025
Psilocybin
Psilocybin in the study comes in the form of the study drug, PYEX. PYEX is a drug substance which is a partially purified fraction of the extract of Psilocybe cubensis mushroom fruiting bodies. It is a mixture of indole alkaloids, other mushroom fruiting body components and stabilization excipients. The major indole alkaloids present include psilocybin and psilocin (dephosphorylated psilocybin). PEX010 is a capsule for oral administration and is manufactured with PYEX (12.5-14.0% psilocybin), excipients, and HPMC (hydroxypropyl methyl cellulose) capsules.
RECRUITING
Centre for Neurology Studies, Surrey
Lead Sponsor
Collaborators (1)
Empower Psychedelics
UNKNOWN
Centre for Neurology Studies, Canada
UNKNOWN
Mitacs
INDUSTRY
Empower Research Inc
INDUSTRY